BIOGEN INC. Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities
BIOGEN INC. (BIIB) reported Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities of $3.60 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-03.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2022-02-03
- BIOGEN INC. unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2019 was $3.60M, a 23.40% decline from fiscal 2018.
- BIOGEN INC. unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2018 was $4.70M.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2019-12-31 | $3.60M 10-K · filed 2022-02-03 |
| 2018-12-31 | $4.70M 10-K · filed 2021-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |